Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Mediators of Inflammation
Volume 2016, Article ID 1320365, 10 pages
http://dx.doi.org/10.1155/2016/1320365
Research Article

Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis

1Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street, Harbin, Heilongjiang 150001, China
2Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Harbin, Heilongjiang 150001, China

Received 1 October 2016; Revised 12 November 2016; Accepted 17 November 2016

Academic Editor: Yong Wu

Copyright © 2016 Yunan Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. G. Hozayen and H. S. Abou Seif, “Protective effects of rutin and hesperidin against doxorubicin-induced lipodystrophy and cardiotoxicity in albino rats,” Journal of American Science, vol. 7, pp. 765–775, 2011. View at Google Scholar
  2. L. Gianni, E. H. Herman, S. E. Lipshultz, G. Minotti, N. Sarvazyan, and D. B. Sawyer, “Anthracycline cardiotoxicity: from bench to bedside,” Journal of Clinical Oncology, vol. 26, no. 22, pp. 3777–3784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Yagmurca, O. Bas, H. Mollaoglu et al., “Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats,” Archives of Medical Research, vol. 38, no. 4, pp. 380–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Swain, F. S. Whaley, and M. S. Ewer, “Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials,” Cancer, vol. 97, no. 11, pp. 2869–2879, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. D. von Hoff, M. W. Layard, P. Basa et al., “Risk factors for doxorubicin-induced congestive heart failure,” Annals of Internal Medicine, vol. 91, no. 5, pp. 710–717, 1979. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Hudson, K. K. Ness, J. G. Gurney et al., “Clinical ascertainment of health outcomes among adults treated for childhood cancer,” The Journal of the American Medical Association, vol. 309, no. 22, pp. 2371–2381, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Strumberg, S. Brügge, M. W. Korn et al., “Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer,” Annals of Oncology, vol. 13, no. 2, pp. 229–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. van Acker, K. Kramer, J. A. Grimbergen, D.-J. Van den Berg, W. J. F. Van der Vijgh, and A. Bast, “Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity,” British Journal of Pharmacology, vol. 115, no. 7, pp. 1260–1264, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. X. L. Yang, C. H. Fan, and H. S. Zhu, “Photo-induced cytotoxicity of malonic acid [C60] fullerene derivatives and its mechanism,” Toxicology in Vitro, vol. 16, no. 1, pp. 41–46, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. L. M. Grant and D. C. Rockey, “Drug-induced liver injury,” Current Opinion in Gastroenterology, vol. 28, no. 3, pp. 198–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Octavia, C. G. Tocchetti, K. L. Gabrielson, S. Janssens, H. J. Crijns, and A. L. Moens, “Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 6, pp. 1213–1225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Yang, S. S. Teves, C. J. Kemp, and S. Henikoff, “Doxorubicin, DNA torsion, and chromatin dynamics,” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, vol. 1845, no. 1, pp. 84–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Li, G. Takemura, Y. Li et al., “Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy,” Circulation, vol. 113, no. 4, pp. 535–543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhao, J. Zhang, N. Tong, Y. Chen, and Y. Luo, “Protective effects of berberine on doxorubicin-induced hepatotoxicity in mice,” Biological and Pharmaceutical Bulletin, vol. 35, no. 5, pp. 796–800, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. James, H. M. Cochemé, and M. P. Murphy, “Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing,” Mechanisms of Ageing and Development, vol. 126, no. 9, pp. 982–986, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Ohsawa, M. Ishikawa, K. Takahashi et al., “Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals,” Nature Medicine, vol. 13, no. 6, pp. 688–694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhang, Q. Wu, S. Song et al., “Effect of hydrogen-rich water on acute peritonitis of rat models,” International Immunopharmacology, vol. 21, no. 1, pp. 94–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Hayashida, M. Sano, N. Kamimura et al., “Hydrogen inhalation during normoxic resuscitation improves neurological outcome in a rat model of cardiac arrest independently of targeted temperature management,” Circulation, vol. 130, no. 24, pp. 2173–2180, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. K.-I. Fukuda, S. Asoh, M. Ishikawa, Y. Yamamoto, I. Ohsawa, and S. Ohta, “Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress,” Biochemical and Biophysical Research Communications, vol. 361, no. 3, pp. 670–674, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. F. Zhang, Q. Sun, B. He, J. Xiao, Z. Wang, and X. Sun, “Anti-inflammatory effect of hydrogen-rich saline in a rat model of regional myocardial ischemia and reperfusion,” International Journal of Cardiology, vol. 148, no. 1, pp. 91–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zheng, K. Liu, Z. Kang et al., “Saturated hydrogen saline protects the lung against oxygen toxicity,” Undersea and Hyperbaric Medicine, vol. 37, pp. 185–192, 2010. View at Google Scholar · View at Scopus
  22. P. Angsutararux, S. Luanpitpong, and S. Issaragrisil, “Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 795602, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. I. Morsi, A. E. Hussein, M. Mostafa, E. El-Abd, and N. A. Abd El-Moneim, “Evaluation of tumour necrosis factor-α, soluble P-selectin, γ-glutamyl transferase, glutathione S-transferase-π and α-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy,” British Journal of Biomedical Science, vol. 63, no. 2, pp. 74–78, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Mukherjee, S. K. Banerjee, M. Maulik, A. Kumar Dinda, K. K. Talwar, and S. Kumar Maulik, “Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-α expression,” BMC Pharmacology, vol. 3, article 16, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Seo, R. Kurokawa, and B. Sato, “A convenient method for determining the concentration of hydrogen in water: use of methylene blue with colloidal platinum,” Medical Gas Research, vol. 2, no. 1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Liu, R. Kurokawa, M. Fujino, S. Hirano, B. Sato, and X.-K. Li, “Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes,” Scientific Reports, vol. 4, article 5485, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Malhi and G. J. Gores, “Cellular and molecular mechanisms of liver injury,” Gastroenterology, vol. 134, no. 6, pp. 1641–1654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Sun, L. Chen, W. Zhou et al., “The protective role of hydrogen-rich saline in experimental liver injury in mice,” Journal of Hepatology, vol. 54, no. 3, pp. 471–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Ghigo, M. Li, and E. Hirsch, “New signal transduction paradigms in anthracycline-induced cardiotoxicity,” Biochimica et Biophysica Acta, vol. 1863, pp. 1916–1925, 2016. View at Publisher · View at Google Scholar
  30. J. Shi and L. Wei, “Rho kinase in the regulation of cell death and survival,” Archivum Immunologiae et Therapiae Experimentalis, vol. 55, no. 2, pp. 61–75, 2007. View at Publisher · View at Google Scholar · View at Scopus